Your browser doesn't support javascript.
Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
Bilal, Muhammad; Iqbal, Hafiz M N.
  • Bilal M; School of Life Science and Food Engineering, Huaiyin Institute of Technology , Huaian, China.
  • Iqbal HMN; Tecnologico de Monterrey, School of Engineering and Sciences, Campus Monterrey , Monterrey, Mexico.
Hum Vaccin Immunother ; 16(12): 3034-3042, 2020 12 01.
Article in English | MEDLINE | ID: covidwho-730555
ABSTRACT
The novel coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has rapidly spread across the world. This resulted an alarming number of fatalities with millions of confirmed infected cases, pretending severe public health, economic, and social threats. There is no specific therapeutic drugs or licensed vaccines or treatments to fight against lethal COVID-19 infections. Given the significant threats of COVID-19, the global organizations are racing to identify epidemiological and pathogenic mechanisms of COVID-19 to find treatment regimens and effective therapeutic modalities for future prevention. Herein, we reviewed the therapeutic interventions and vaccines for COVID-19 based on the existing knowledge and understanding of similar coronaviruses, including MERS-CoV and SARS-CoV. The information constitutes a paramount intellectual basis to sustenance ongoing research for the discovery of vaccines and therapeutic agents. This review signifies the most available frontiers in the viral vaccine development approaches to counter the COVID-19/SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Coronavirus Infections / Severe Acute Respiratory Syndrome / COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Animals / Humans Language: English Journal: Hum Vaccin Immunother Year: 2020 Document Type: Article Affiliation country: 21645515.2020.1794685

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Coronavirus Infections / Severe Acute Respiratory Syndrome / COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Animals / Humans Language: English Journal: Hum Vaccin Immunother Year: 2020 Document Type: Article Affiliation country: 21645515.2020.1794685